|
ETFMG U.S. Alternative Harvest ETF | MJUS | Invesco S&P 500® Low Volatility ETF | SPLV | Zoetis Inc | ZTS | iShares Core S&P 500 ETF | IVV | Maxlinear Inc | MXL | Putnam Focused Large Cap Value ETF | PVAL | Eli Lilly and Co | LLY | ARK Innovation ETF | ARKK | Kelly Residential & Apartment Real Estate ETF | RESI | ARK Fintech Innovation ETF | ARKF |
Gross Expense Ratio*
0.75%
SEC 30 Day Yield (as of 04/29/22 )
--
Ann. Dividend/Yield
No Regular Dividends
Fund Inception
05/12/2021
|
 Loading...
The chart is currently unavailable.
|
The investment seeks income and long-term growth of capital.The fund seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the “Cannabis Business” in the United States, and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology and life sciences industry group. The fund is non-diversified.
|
Market Return % (as of 04/30/2022) |
NAV Return % (as of 04/30/2022) |
Market Return % (as of 03/31/2022) |
NAV Return % (as of 03/31/2022) |
1-Month |
-25.56% |
-26.65% |
-2.03% |
-3.78% |
3-Month |
-26.60% |
-27.28% |
-16.72% |
-27.28% |
6-Month |
-45.63% |
-46.76% |
-36.04% |
-36.10% |
Year-to-date |
-38.01% |
-38.90% |
-16.72% |
-16.70% |
1-Year |
-- |
-- |
-- |
-- |
3-Year |
-- |
-- |
-- |
-- |
5-Year |
-- |
-- |
-- |
-- |
10-Year |
-- |
-- |
-- |
-- |
Since Inception |
-63.30% |
-63.82% |
-50.70% |
-50.68% |
Inception Date: May 12, 2021
Performance Details
Total return reflects performance without adjusting for sales charges or the effects of taxation, but is adjusted to reflect all actual ongoing fund expenses and assumes reinvestment of dividends and capital gains. If adjusted, sales charges would reduce the performance quoted. Performance data quoted represents past performance, is no guarantee of future results, and may not provide an adequate basis for evaluating the performance potential of the product over varying market conditions or economic cycles. Current performance may be higher or lower than the performance data quotes. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost.
|
Market Return % (as of 04/30/2022) |
NAV Return % (as of 04/30/2022) |
Market Return % (as of 03/31/2022) |
NAV Return % (as of 03/31/2022) |
1-Year |
-- |
-- |
-- |
-- |
5-Year |
-- |
-- |
-- |
-- |
10-Year |
-- |
-- |
-- |
-- |
Since Inception |
-63.30% |
-63.82% |
-50.70% |
-50.68% |
Inception Date: May 12, 2021
0.00% |
10.43% |
0.00% |
0.00% |
52.29% |
0.00% |
41.86% |
0.00% |
0.00% |
20.97% |
20.97% |
0.00% |
0.00% |
0.00% |
12.83% |
0.00% |
26.74% |
13.91% |
Portfolio Details
|
* represents an International company or one without a recognizable symbol.
Portfolio Details
|
|
|